Aggressive healthcare property roll-up caters almost exclusively to distressed tenants. Rent is round-tripped via “fake” purchases of massively inflated assets. The fat lady is singing. January 26, 2023 – Viceroy Research is short Medical Properties Trust (NASDAQ : MPW), a healthcare property REIT who has
SBB humiliates shareholders with absurd and untrue announcements surrounding the success of its incompetent dealmakers. December 8, 2022 – SBB announced it had sold a stake in its newly-formed EduCo to Brookfield on November 30,2022[1]. It then proceeded to defecate on a plate and present
November 30, 2022 –Home REIT today published its response to Viceroy’s report: “No Place Like Home REIT”. This response all but confirms round-tripping of revenues to tenants via vendor agreements, low tenant quality and related party structures between major tenants. This document will address Home
November 23, 2022 – Home REIT (LSE:HOME) acquires “B&B” accommodation assets and rents them out to charities, housing associations or community interest companies in the UK. Viceroy’s investigation of Home REIT’s investments and tenants suggests significant downside. Poor operating results are already reflected in Home
October 5, 2022 – On October 3, 2022 – Truecaller released a press statement in response to Viceroy’s report, Truecaller’s True Colors, on October 3, 2022. As expected, Truecaller’s statement fell squarely within the clutches of Catch-22 (the greatest catch there is). Here at Viceroy,
Truecaller’s app facilitates strangers’ contact with minors without valid consent. PLEASE READ IMPORTANT DISCLAIMER – PAGE 3 September 29, 2022 – Viceroy research has fielded calls from concerned data protection specialists in India in relation to how Truecaller handles consent for minors. Truecaller sign-up does
September 28, 2022 – Truecaller (TRUEB:SS) is a Swedish adware & spyware app which feeds an inferior caller-identification service aimed at detecting spam. The EU’s General Data Protection Regulation (GDPR), and similar legislation across the globe, threatens Truecaller’s business, which we believe is on the
June 22, 2022 – Viceroy’s deeper review into SBB’s financial accounts have presented material reconciliation challenges which our team, together with various expert consultants, cannot reconcile. This challenge stems from SBB’s consolidation of acquisitions, which we believe to be incorrect and unjustly inflating asset values.
May 3, 2022 – In anticipation of Adler Group’s investor call today Viceroy have prepared some questions regarding their annual report regarding recent development. In addition to these questions, Viceroy have found significant discrepancies in Adler’s LTV calculations as well as management’s claim that the
April 29, 2022 – On 22 April 2022, Adler released KMPG’s special investigation report into the Adler Group and its subsidiaries. KPMG’s findings (or lack thereof, given Adler’s apparent unwillingness to cooperate) are hilariously damning. In a moment of pure lunacy: Adler management claims KPMG’s
Viceroy Research LLC are an investigative financial research group registered in Delaware, USA.
Our research reports have been prepared for educational purposes only and expresses our opinions. Our reports and any statements made in connection with them are the authors’ opinions, which have been based upon publicly available facts, field research, information, and analysis through our due diligence process, and are not statements of fact. All expressions of opinion are subject to change without notice, and we do not undertake to update or supplement any reports or any of the information, analysis and opinion contained in them. We believe that the publication of our opinions about public companies that we research is in the public interest. We are entitled to our opinions and to the right to express such opinions in a public forum. You can access any information or evidence cited in this report or that we relied on to write this report from information in the public domain.
To the best of our ability and belief, all information contained herein is accurate and reliable, and has been obtained from public sources we believe to be accurate and reliable, and who are not insiders or connected persons of the stocks covered herein or who may otherwise owe any fiduciary duty or duty of confidentiality to the issuer. We have a good-faith belief in everything we write; however, all such information is presented “as is,” without warranty of any kind – whether express or implied.
In no event will we be liable for any direct or indirect trading losses caused by any information available on this report. Think critically about our opinions and do your own research and analysis before making any investment decisions. We are not registered as an investment advisor in any jurisdiction. By downloading, reading or otherwise using our research reports, you agree to do your own research and due diligence before making any investment decision with respect to securities discussed herein, and by doing so, you represent to us that you have sufficient investment sophistication to critically assess the information, analysis and opinions in this report. You should seek the advice of a security professional regarding your stock transactions.
This website, all documents contained herein or any information herein should not be interpreted as an offer, a solicitation of an offer, invitation, marketing of services or products, advertisement, inducement, or representation of any kind, nor as investment advice or a recommendation to buy or sell any investment products or to make any type of investment, or as an opinion on the merits or otherwise of any particular investment or investment strategy.
Any examples or interpretations of investments and investment strategies or trade ideas are intended for illustrative and educational purposes only and are not indicative of the historical or future performance or the chances of success of any particular investment and/or strategy.
You should assume that the authors have a direct or indirect interest/position in all stocks (and/or options, swaps, and other derivative securities related to the stock) and bonds covered herein, and therefore stand to realize monetary gains in the event that the price of either declines.
The authors may continue transacting directly and/or indirectly in the securities of issuers covered herein for an indefinite period and may be long, short, or neutral at any time hereafter regardless of their initial recommendation.